George Tachas

George Tachas

Company: Antisense Therapeutics

Job title: Director of Drug Discovery & Patents


Learning How Systemically Delivering Antisense Oligonucleotides Targeting CD49d RNA (ATL1102) Significantly Reduces New Active Brain Lesions in Patients With Relapse Remitting-Multiple Sclerosis 9:00 am

Analyzing Pharmacodynamics: Focus on circulating white blood cell observations Comprehensively analyzing safety data and pharmacokinetics Deep diving into the pharmacology of ASOs in the brainRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.